Sleeping Bruxism Treatment Market Size, Share & Industry Analysis, By Product Type (Mouth Guards, Splints, and Others), By Patient Type (Adults, and Pediatric), By End-user (Hospitals, Dental Clinics, Homecare, and Others), and Regional Forecast, 2025-2032

The global sleeping bruxism treatment market size was valued at USD 543.7 million in 2024. The market is projected to grow from USD 577.8 million in 2025 to USD 914.4 million by 2032, exhibiting a CAGR of 6.8% during the forecast period. North America dominated the sleeping bruxism treatment market with a market share of 32.72% in 2024.

Sleep bruxism is a condition in which a person involuntarily clenches or grinds their teeth during sleep, often without being aware of it. This sleep-related movement disorder may lead to jaw pain, headaches, or worn teeth, and is often linked to stress or sleep problems, further requiring treatment. The global market growth is significantly driven by increasing cases of anxiety, stress, sleep disorders, and other related conditions including obstructive sleep apnea, which are increasing the risk of sleeping bruxism. Other factors driving the treatment rate for such conditions include increasing public awareness, improved diagnostic technologies, and rising demand for non-invasive and personalized products such as mouth guards and splints. Moreover, access to such products is expanding through hospitals, clinics, and online pharmacies.

Furthermore, the market is dominated by major players such as Procter & Gamble (Plackers), Smile Brilliant, and others. The growth of these companies is supported by their broader product portfolio and involvement in strategic initiatives to expand market presence.

MARKET DYNAMICS

MARKET DRIVERS

Increasing Prevalence of Sleeping Bruxism to Propel the Market Growth

In recent years, there has been a significant rise in the prevalence of sleeping bruxism across the globe. This high prevalence rate of developing symptoms including jaw pain and tooth wear among millions of people, boosting demand for diagnosis and management solutions. The prevalence is also expected to increase due to growing number of cases of sleep apnea and other related conditions.

• For instance, according to the Journal of Clinical Sleep Medicine in March 2023, a study conducted at Chulalongkorn University, Bangkok, Thailand, reported that around half (49.7%) of adults with obstructive sleep apnea (OSA) have sleep bruxism (SB). Males with lower body mass index, and those with more light sleep (N1 stage) are more likely to have SB.

Moreover, as awareness grows and more people seek support for sleep-related tooth grinding, the demand for sleeping bruxism treatments, such as OTC and custom mouth guards and splints, is expected to increase rapidly, thereby driving the market growth.

MARKET RESTRAINTS

Limited Adoption of Treatment Among Patients to Restrict Market Expansion

Globally, there is a limited actual treatment rate among sleeping bruxism patients despite the relatively high prevalence. Several individuals with sleep bruxism do not seek or receive a diagnosis and proper management due to limited awareness, underreporting of symptoms, and limited effective, as well as universally accepted, treatment options.

This gap between prevalence and treatment rate is hindering the usage of devices such as mouth guards and splints, which is anticipated to hamper the market growth during the forecast period.

• For instance, according to the data published by the Odovtos International Journal of Dental Sciences in April 2020, a study by the Department of Pediatric Dentistry, Osmangazi University, Turkey, mentioned that the proportion of parents seeking treatment for their children for bruxism was only 3.8%.

MARKET OPPORTUNITIES

Smart Mouth Guards with Biofeedback Features to Create Lucrative Growth Opportunities

Smart mouth guards protect teeth from grinding, along with monitoring of jaw activity, muscle tension, and provide real-time feedback to users. This biofeedback trains individuals to reduce bruxism episodes through behavioral adjustments, offering both protection and preventive therapy. Moreover, the growing demand for connected and user-friendly solutions is rising, which is creating a significant opportunity for key players to develop and expand the availability of smart mouth guards in the global market.

• For instance, according to the data published by the Cleveland Clinic in October 2023, Prevent Biometrics’ Intelligent Mouthguard technology captures every head impact, then transmits the data wirelessly via Bluetooth to an iPhone, providing precise measurements of both linear and angular accelerations and speeds.

SLEEPING BRUXISM TREATMENT MARKET TRENDS

Advances in Custom-Fit and 3D Printing Technologies to Emerge as a Key Market Trend

Advances in custom-fit and 3D printing technologies are transforming the bruxism treatment by enabling highly personalized mouth guards that offer superior comfort and protection. 3D printing has allowed for precise fabrication based on digital scans of an individual’s oral structure, significantly improving device fitting and reducing production time. These manufacturing innovations are enabling rapid prototyping and customization at a lower cost compared to traditional methods.

Additionally, new biocompatible materials designed for 3D printing are enhancing the durability of mouth guards. As a result, key players are combining 3D printing with sensor integration to create smart mouth guards that protect as well as monitor jaw activity, delivering personalized feedback. Furthermore, the ability to custom-fitted devices based on a patient’s mouth anatomy is boosting its demand, especially among athletes and patients with sleep bruxism.

MARKET CHALLENGES

Alternative Treatment Options to Hamper Market Growth

Currently, several patients prefer non-device-based solutions such as behavioral therapies, Botox injections, and muscle relaxants, which are less invasive. These alternatives can reduce demand for device-based treatments like mouth guards and splints, limiting market penetration. Moreover, the stringent regulatory scenario for new devices is expected to delay their market entry and slow down their adoption.

Such a diversity of treatment preferences and the availability of multiple therapeutic options are creating challenges for key players to focus solely on device-based solutions, potentially hampering sleeping bruxism treatment market growth.

• For instance, according to the article published by the National Center for Biotechnology Information (NCBI) in July 2023, Botulinum toxin injection is an effective treatment option, particularly for patients who do not respond well to conventional therapies or have poor compliance with those treatments.

Request a Free sample to learn more about this report.

Segmentation Analysis

By Product Type

Mouth Guards Segment to Lead the Market Due to their Ease of Access

On the basis of the segmentation of product type, the market is classified into mouth guards, splints, and others.

The mouth guards segment accounted for the dominant global sleeping bruxism treatment market share in 2024. The growth is attributed to its affordability and OTC availability, as well as its custom-fitted design, which is increasing the ease of access and increasing its demand among patients. As a result, the key players are launching new products, thereby increasing product availability.

• For instance, in November 2023, Quip launched custom-fit "Quip Night Guards" to expand professional-grade solutions into the homes of consumers everywhere. 

To know how our report can help streamline your business, Speak to Analyst

By Patient Type

Adult Segment to Dominate Due to Higher Necessity for the Treatment

By patient type, the market is categorized into adults and pediatrics.

The adult segment captured the largest share of the market in 2024. In 2025, the segment is anticipated to dominate with a 76.1% share. Bruxism in adults is associated with TMD (temporomandibular disorders), headaches, cracked teeth, etc., making treatment more clinically necessary. This is expected to increase usage of bruxism devices among adults, thereby boosting the segment’s growth in the coming years.

The pediatric segment is expected to grow at a CAGR of 6.4% over the forecast period.  

By End-user

Active Involvement in Genome-based Research Activities by Pharmaceutical & Biotechnology Companies Propelled Segment Growth

Based on end-user, the market is segmented into hospitals, dental clinics, homecare, and others.

In 2024, the global market was dominated by dental clinics in terms of end-user. Most custom-fitted devices are prescribed and fitted at dental clinics. Additionally, in developed countries, patients prefer dentist-prescribed splints rather than buying OTC guards. Moreover, the treatment rate among children for bruxism treatments is increasing in dental settings, which is expected to contribute to the segment’s growth. Furthermore, the segment is set to hold 41.5% share in 2025.

• For instance, according to the data published by the Odovtos International Journal of Dental Sciences in April 2020, a study by the Department of Pediatric Dentistry, Osmangazi University, Turkey reported that the majority of the parents (37.7%) seek bruxism treatment for their children from dentists.

In addition, the homecare segment is projected to grow at a CAGR of 6.8% during the forecast period.

Sleeping Bruxism Treatment Market Regional Outlook

By geography, the market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America

[QMcwPgxuBX]

The North America held the dominant share in 2023 valuing at USD 167.0 million and also took the leading share in 2024, with USD 177.9 million. The region has high adult prevalence rates of sleep bruxism, leading to greater device demand. Moreover, the countries in the region, such as the U.S. and Canada, have a high density of dentists per capita, which is accelerating both diagnosis and device prescribing, which is expected to drive the region’s market growth. In 2025, the U.S. market is estimated to reach USD 167.4 million.

• For instance, according to the data from the American Dental Association, in 2024, the U.S. had 202,485 professionally active dentists, which equals 59.5 dentists for every 100,000 people.

Europe and  Asia Pacific

Other regions, such as Europe and the Asia Pacific, are projected to expand at a notable rate in the forthcoming years. During the forecast period, the Europe region is projected to record the growth rate of 6.9%, which is the second highest amongst all the regions, and reach the valuation of USD 158.6 million in 2025. This is primarily due to the routinely screening for bruxism during checkups, leading to higher treatment rates with mouth guards and splints. Backed by these factors, countries including U.K. anticipates to record the valuation of USD 23.1 million, Germany to record USD 33.3 million, and France to record USD 21.5 million in 2025.  After Europe, the market in Asia Pacific is estimated to reach USD 155.8 million in 2025 and secure the position of the third-largest region in the market. In the region, India and China are both estimated to reach USD 28.4 million and 55.9 million, respectively in 2025.

Latin America and Middle East & Africa

Over the forecast period, Latin America and Middle East & Africa regions would witness a moderate growth in the market. Latin America market in 2025 is set to record USD 40.9 million as its valuation. The growth is attributed to growing awareness of bruxism treatment and key players entering in the region with advanced products. In the Middle East & Africa, GCC is set to attain the value of USD 21.4 million in 2025.

COMPETITIVE LANDSCAPE

Key Industry Players

Wide Range of Product Offerings and Growing Adoption of Customized Devices Strengthened the Leading Position of Key Players

The global sleeping bruxism treatment market is moderately consolidated, with key players such as SomnoMed, Procter & Gamble, Dentsply Sirona, and Smile Brilliant.

These companies are focusing on producing customized mouth guards and splints, innovative materials, and digital fabrication technologies. Additionally, their focus on strategic partnerships with dental service providers and expansion into online channels is supporting their market positions.

Moreover, other notable companies, including Ivoclar Vivadent, Henry Schein, and Quip, are emphasizing strategies such as direct-to-consumer custom-fit guard offerings, 3D printing integration, and others to increase their reach among both clinicians and consumers.

LIST OF KEY SLEEP BRUXISM TREATMENT COMPANIES PROFILED

• Prestige Consumer Healthcare Inc. (U.S.)
• Procter & Gamble (Ireland)
• Smile Brilliant (U.S.)
• Dentsply Sirona (U.S.)
• Ivoclar Vivadent (Liechtenstein)
• SomnoMed (Australia)
• Henry Schein, Inc. (U.S.)
• Sunstar Group (Switzerland)
• ResMed (U.S.)

KEY INDUSTRY DEVELOPMENTS

• October 2024: Slow Wave Inc.’s BROSA, a bruxism device, received FDA clearance for the treatment of sleep bruxism.
• January 2024: The University at Buffalo’s dental school partnered with UB Athletics to provide custom mouth guards for the football team’s upcoming season.
• December 2023: Aesyra SA raised USD 3.0 million in seed financing in late 2023 to advance its AesyBite line of oral appliances for sleep bruxism.
• September 2021: Aesyra SA developed a smart oral appliance, AesyBite, that reduces bruxism by relaxing muscles during sleep.
• November 2020: Dentsply Sirona signed an exclusive agreement with Panthera Dental to offer a validated, fully digital workflow for custom sleep / oral appliance devices (including bruxism/splint workflows.

REPORT COVERAGE

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation